Early infection prediction after breast reconstruction surgery

New biomarkers can predict post-surgery infections in breast reconstruction patients before symptoms appear. Researchers identified specific metabolites in fluid samples that indicate infection days or weeks prior to clinical signs, allowing for early intervention. This discovery could lead to a point-of-care test, improving outcomes, reducing implant loss, and aiding antibiotic stewardship.